Back to Search Start Over

Flecainide to prevent atrial arrhythmia after patent foramen ovale closure, Rationale and design of the randomized AFLOAT study

Authors :
Hauguel-Moreau, Marie
Guedeney, Paul
Dauphin, Claire
Auffret, Vincent
Marijon, Eloi
Aldebert, Philippe
Clerc, Jean-Michel
Beygui, Farzin
Elbaz, Meyer
Khalil, Wissam Abi
Da Costa, Antoine
Macia, Jean-Christophe
Elhadad, Simon
Cayla, Guillaume
Brugier, Delphine
Silvain, Johanne
Hammoudi, Nadjib
Duthoit, Guillaume
Vicaut, Eric
Montalescot, Gilles
Source :
European Heart Journal - Cardiovasular Pharmacotherapy; April 2024, Vol. 10 Issue: 3 p184-189, 6p
Publication Year :
2024

Abstract

Graphical AbstractDesign of the AFLOAT trial; AA: atrial arrhythmia; ICM = insertable cardiac monitor; od = once a day; PFO = patent foramen ovale; SR = sustained-release.

Details

Language :
English
ISSN :
20556837 and 20556845
Volume :
10
Issue :
3
Database :
Supplemental Index
Journal :
European Heart Journal - Cardiovasular Pharmacotherapy
Publication Type :
Periodical
Accession number :
ejs66453821
Full Text :
https://doi.org/10.1093/ehjcvp/pvad100